Hereditary sensory and autonomic neuropathy type IV (HSAN IV) is caused by mutations in the tyrosin kinase A (TrkA) gene, encoding for the high-affinity receptor of nerve growth factor (NGF). The NGF-TrkA system is expressed in many endocrine glands. We hypothesized that HSAN IV represents a natural model for impaired NGF effect on the neuroendocrine system in humans. We have documented the clinical outcome of 31 HSAN IV patients in a single medical center, and investigated their basal endocrine system status. The endocrine system response to thirst was compared between six patients and six healthy children. High rates of mortality (22%) and severe morbidity (30%) have been found in HSAN IV patients. Hypothermia was noted in 40% of the patients and unexplained fever was observed in 56%. Subnormal adrenal function was demonstrated in six (30%) of the patients studied. Furthermore, we found lower plasma norepinephrine (NE) levels in six HSAN IV patients compared with a control group after the thirst test. Our findings emphasize the importance of NGF-TrkA pathway in the physiology of the neuroendocrine system and its response to stress. Inadequate response to stress might contribute to the observed significant mortality, morbidity, and temperature instability in HSAN IV patients. (Pediatr Res 57: 587-590, 2005) Abbreviations HPA axis, hypothalamic-pituitary-adrenocortical axis HSAN IV, hereditary sensory and autonomic neuropathy type IV IGFBP3, IGF binding protein 3 LDAT, low-dose ACTH test NE, norepinephrine NGF, nerve growth factor SDS, standard deviation score TrkA, tyrosine kinase A HSAN IV (OMIM 256800), also known as congenital insensitivity to pain with anhidrosis, belongs to a group of rare autosomal recessive peripheral sensory neuropathies. It involves the loss of pain sensation, which leads to fractures and skin lacerations often evolving into deep wounds, with complications such as osteomyelitis, septic arthritis, and Charcot joints. Moderate-to-severe mental retardation is present in most of the patients, and this combination of insensitivity to pain and mental retardation seems to lead to self-mutilation of the tongue and fingertips with frequent autoamputations. Anhidrosis, another prominent component of the disorder, is often associated with recurrent episodes of unexplained fever, which can be fatal (1) (2) (3) . Typical histologic findings include a complete absence of nonmyelinated and small myelinated nerve fibers in the dorsal root ganglia and normal number and structure of the sweat glands, but lack of the innervations of small diameters neurons (4) .
HSAN IV was previously diagnosed only by characteristic clinical findings. However, recently, mutations in the TrkA gene, encoding the high-affinity receptor for NGF, have been implicated in the pathogenesis of HSAN IV (5) (6) (7) (8) . NGF induces neural outgrowth and promotes survival of embryonic sensory and sympathetic neurons (9, 10) . In addition to its trophic function, NGF seems to be involved in a phenomena related to HPA axis activity (11) (12) (13) (14) .
In view of recent advances in the understanding of the pathophysiology of HSAN IV, we have conducted a study to evaluate the basic endocrine status and the adaptation of patients with HSAN IV to stress stimuli by assessing the integrity of the HPA axis and the catecholamine response during thirst.
RESULTS
Morbidity and mortality in HSAN IV patients. Seven out of 31 patients (23%) died. The age of death ranged between 40 d and 7 y. Five patients (16%) died before their first birthday. Two patients (6.5%) were 7 y old at death.
The causes of death were infectious diseases, cardiac arrest, or unknown causes. Nine of the patients (33%) were admitted to the pediatric intensive care unit due to neonatal hypothermia, septic shock, and cardiac arrest. Four of these patients died.
Anesthetic complications. Twenty-two of the patients (73%) had at least one surgical procedure under general anesthesia. Most of the patients had more than one surgical procedure. These procedures included limb amputations, drainage of deep soft tissues abscesses or chronic osteomyelitis, teeth extraction and ophthalmic surgeries. Four out of 22 patients (18%) had major complications, including hypothermia (two patients), cardiac arrest, and hypotension after surgery.
Hyperthermia was not evident in any of the patients during or after anesthesia. After our adoption of an anesthetic policy in HSAN IV patients, which included intensive cardiopulmonary and body temperature monitoring of the patients, no adverse anesthetic events have been recorded.
Vital signs. Hypothermia was found in 12 of our patients (39%). Ten patients showed neonatal hypothermia and, in seven (70%), hypothermia had been recorded during a proven bacterial infection. Asymptomatic hypothermia was noted in 7 out of 17 of the HSAN IV patients (40%) during their routine follow-up visits. Unexplained fever was found in 17 patients (54%).
Blood pressure and pulse rate measurements of patients were appropriate for their age and sex during their regular clinic visits.
Growth. Weight, height, and growth rate were recorded in 21 patients (68%). SDS of these parameters were calculated. We found that 9/21 HSAN IV patients (41%) had height SDS below Ϫ2 (Z ϭ 7.9, n Ͼ 1.96, p Ͻ 0.01) and 6/21 (28%) had SDS for weight below Ϫ2 (Z ϭ 4.96, n Ͼ 1.96, p Ͻ 0.01). Growth rate was slower in patients with HSAN IV. The prevalence of growth rate SDS below Ϫ1 was 11/18 (60%) (Z ϭ 10, n Ͼ 2.38, p Ͻ 0.01).
Basal endocrine studies. Basal glucose, electrolytes, thyroxine, TSH, and prolactin plasma levels were studied in 20 HSAN IV patients and were found to be within normal range, except in one patient with primary hypothyroidism. This patient had normal thyroid function at the time of neonatal screening (data not shown).
SDS for mean plasma IGF-I levels were Ϫ1 Ϯ 0.6. Only one patient (5%) had a SDS for plasma IGF-I levels below Ϫ2 (NS). SDS for mean plasma IGFBP3 levels were Ϫ1.3 Ϯ 0.8, and four patients (20%) had plasma IGFBP3 SDS below Ϫ2 (Z ϭ 3.0, n Ͼ 1.96, p Ͻ 0.01).
Adrenal function. Eleven patients (55%) had random plasma cortisol levels Ͻ276 nmol/L. LDAT had been performed in eight of these patients (73%). Subnormal response (i.e. cortisol Ͻ600 nmol/L) was present in six patients, including two patients whose cortisol response was Ͻ400 nmol/L. Thus, at least 30% (6/20) of the patients tested had evidence of HPA axis dysfunction.
Thirst test results. The demographic and clinical background of six HSAN IV patients and six control participants in the thirst test are described in Table 1 . The test was prematurely terminated in three of the HSAN IV patients (50%) due to fever rising above 39.3°C (two patients) and irritability with hypotension in one patient. In a single control subject, the test was terminated after maximal urinary specific gravity was achieved. There were no differences in average blood pressure, pulse, respiratory rates, and urine osmolalities before and after the test in both study groups (data not shown).
We found that the patients' body temperature had increased during the test by 1.2 Ϯ 1.4°C in comparison to Ϫ0.1 Ϯ 0.5°C in the control group (p ϭ 0.041).
The endocrine test results before and after the thirst test are shown in Table 2 . Plasma cortisol levels were similar in both groups before and after the thirst test. Cortisol levels increased in the HSAN IV group from 205 Ϯ 74.5 nmol/L to 380 Ϯ 184 nmol/L after the test (p ϭ 0.028).
17OH-progesterone levels increased significantly in both groups after the tests. Plasma NE concentration was lower in the HSAN IV patients at the end of the thirst test, in comparison to the control (0.25 Ϯ 0.14 nmol/L versus 1.07 Ϯ 0.71 nmol/L, p ϭ 0.025).
No significant correlations were found between the levels of NE and blood pressure, heart rate, and respiratory rate.
DISCUSSION
Unexplained fever is a well-recognized clinical feature of HSAN IV patients (1,3,16) . Therefore, the high prevalence of fever without any signs of infection among our patients is not surprising. TrkA is expressed in the hypothalamus, where the preoptic region plays a crucial role in thermoregulation (17) (18) (19) (20) . Absence or decreased TrkA expression at this critical area may explain the observed hyperthermia in HSAN IV. Anhidrosis, caused by deficient innervation of the sweat glands, is also an important factor in the development of fever (16) . Our patients' inability to adequately regulate their body temperature has a particular clinical relevance because they live in a desert terrain.
The unexpected finding of incidental hypothermia in 40% of the patients is intriguing, because this sign had not been previously documented in HSAN IV, except when these patients are exposed to extreme cold (21) . We also found that hypothermia was common during the neonatal period, when it was mainly associated with bacterial infections. Sympathetic response to cold exposure determines the body's thermoregulatory function by dermal vasoconstriction, mediated by skin NE activity (22) . Absence of sympathetic skin response has recently been demonstrated in patients with HSAN IV (23) . Abnormal hypothalamic-mediated thermoregulation combined with a decrease in skin sympathetic activity may explain the high incidence of hypothermic events in our patients.
Our patients had blood pressure and heart rate values that were within the normal range for their age group during routine clinic visits. The retrospective nature of our study precluded a more thorough search for minor changes of pulse and blood pressure during planned study visits.
The NGF-TrkA system is expressed in many endocrine glands such as the hypothalamus, ovary, adrenal, and thyroid glands (17, 24, 25) . It has been noted that NGF has an important role in somatotroph cell differentiation (26, 27) . Dysfunction of the GH-IGF-I axis could not explain the growth retardation in most of our patients, because plasma IGF-I and IGFBP3 levels were within the normal range in all the patients, except for one and four patients, respectively. However, formal GH stimulation tests have not been performed in these patients and normal IGF-I and IGFBP3 plasma levels do not unequivocally rule out GH deficiency (28, 29) .
Rat embryos treated with anti-NGF receptor antibody had small thyroid size (30) . We found only one patient with primary acquired hypothyroidism in our cohort of HSAN IV patients. Alternative compensating mechanisms and decreased physiologic significance of NGF or TrkA as a mediator of NGF effect in human thyroid development may explain the discrepancy between humans and rats in respect to thyroid development.
NGF increases HPA activity in rats (12, 31) . Daily administration of highly purified NGF resulted in a considerable increase in the adrenal gland volume (14) .
We found that at least 30% of the patients had subnormal cortisol response to LDAT. LDAT is a useful, safe, and inexpensive tool for the initial assessment of HPA function in patients with hypothalamic-pituitary disease (15) . LDAT was equivalent to both the standard ACTH test and to insulininduced hypoglycemia in detecting HPA insufficiency in children with idiopathic multiple pituitary hormone deficiencies (32) . It has high diagnostic sensitivity and specificity for primary adrenal insufficiency and can accurately identify subjects with preclinical adrenal dysfunction (33) . Moreover, the performance characteristics of both high-dose (250 g) and low-dose (1 g) ACTH stimulation tests are similar for diagnosing secondary adrenal insufficiency (34) . We assume that the subnormal response to LDAT in some of the HSAN IV patients may be of clinical significance during severe stress. Regarding the grave consequences of adrenal crisis, we recommend preventive hydrocortisone therapy given to a patient with HSAN IV during of life-threatening episodes (i.e. major surgery, severe trauma, sepsis).
It has been recently reported that stress induces secretion of NGF in humans and could elevate the expression of TrkA (35) .
We performed a controlled thirst test, to assess our patients' response to clinically relevant stress. Our findings of elevated plasma 17OH-progesterone levels in the patients and in the control group during the thirst test suggest that the test was 
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ENDOCRINE SYSTEM IN HSAN TYPE IV indeed a stressful procedure. We found significantly low NE levels in the patients compared with controls after the test. Low NE levels were also found in one of our patients during a major surgical procedure and in another patient during an episode of respiratory failure. Our results concur with previously reported low urinary and plasma catecholamine levels following general anesthesia in a small number of HSAN IV patients, compared with healthy controls (36) .
These findings of low NE plasma levels in HSAN IV patients during general anesthesia may explain the risk of these patients developing abnormal body temperature and hypotension during the procedure.
In conclusion, our study demonstrates significant mortality and morbidity associated with impaired regulation of body temperature, and abnormal function of the endocrine system in HSAN IV patients. There is a dire need for further studies to understand the clinical importance of NGF, its high-affinity receptor TrkA, and its effects on body temperature control and the adaptation of the endocrine system to stress.
